Jill Wechsler is ACT's Washington Correspondent

Articles

Amid push to include this population more in clinical trials, the goal is to uncover improved evidence on the risks/benefits of drugs for these patients.

Regulators Seek More Drug Effects Research Related to Pregnancy, Lactation

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Battle lines being drawn among key healthcare constituencies, as discussions around new approaches to drug evaluation and decision-making heat up.

Bringing Evidence Back into Fashion in European Drug Rules

Agency leaders seek to build public trust in science and gain support for regulation.

A Defining Period for Future of FDA

The reporting of one man in Europe is changing accountability with compliance.

Naming and Shaming is Driving Improvements in Reporting of Clinical Trial Results

Measure tackles infant formula, cosmetics, and diagnostics—plus drug development and access. 

FDA User Fee Legislation Advances in Senate

But despite showing a tightening of focus on clinical trials and evidence, the annual report doesn’t paint the full picture.

New EMA Report Highlights Milestones and Momentum

Survey taken by pharma and CRO executives evaluates how effectively various programs convert RWD into usable data.

Data Intermediaries/Software Can Speed the Usage of Real-World Data

Survey taken by pharma and CRO executives evaluates attributes of large datasets.

The Real-World Data That Matters

Professor, Doctor of Medical Science, Head of Department of General Practice – Family Medicine, Kharkiv Medical Academy of Postgraduate Education, Ukraine, a member of WONCA, RCGP, AAFP

Industry must take steps in preserving data for use after the war.

Clinical Trials in Ukraine During the War

Aasma Shaukat, MD, MPH, study co-lead, professor of medicine, and director of outcomes research for the Division of Gastroenterology and Hepatology at New York University Langone Health discusses how sites have evolved since COVID-19.

Blogs